Navigation Links
New Regulation to Check Medication Errors

A new regulation will come to effect from Jan. 5, 2007,that is designed to bring down medication errors across hospitals in California. This regulation will help// pharmacists to be more involved in direct patient care. Otherwise, pharmacists are more involved in non-discretionary (clerical) tasks. The new regulation empowers general acute care hospitals to give jobs to suitably trained pharmacy technicians to check the work of other technicians, to help rule out medication errors that creep in. This helps pharmacists to expand their role in patient care areas. This reduces chances of adverse drug effects in hospitals.

Research studies led by Cedars-Sinai Medical Center and the University of California, San Francisco School of Pharmacy played a key role in the decision to approve this regulation. The results of the first "tech-check-tech" study, which were published in the American Journal of Healthy-System Pharmacy in 2002, demonstrated the safety of having specially-trained technicians check the work of other technicians to prevent medication errors. The research was conducted at Cedars-Sinai and at Long Beach Memorial Medical Center. The second study, just completed, demonstrated the impact of pharmacists on preventing medication errors during the time that they would otherwise have been performing non-discretionary tasks. Historically, any function performed by a pharmacy technician relative to dispensing a prescription had to be verified and documented in writing by a pharmacist, but the new regulation will enable hospital pharmacists to devote their time to activities designed to reduce errors, such as working with physicians and nurses to evaluate medications and ensure the absence of allergies, drug interactions, or patient conditions that would be of concern.

According to Rita Shane, Pharm. D., director of Pharmacy Services at Cedars-Sinai and one of the principal investigators on the study, "A number of studies have demonstrated th
'"/>




Page: 1 2

Related medicine news :

1. Platelets May Be The Source Of Gene Regulations
2. Novel Rules And Regulations For Cardiovascular Catheterization Labs.
3. microRNA And Its Role In Synaptic Regulation
4. Nervous System Plays Role In Stem Cell Regulation
5. Bill for Formal Regulation of Tanning Salons
6. Study Highlights Appetite Regulation Pathway, New Hope for Weight Loss
7. WHO Calls For More Regulation On Tobacco Products
8. Site of Sleep Regulation Identified in Fruit Flies
9. Mechanism of Stem Cell Regulation Identified
10. Natural Approach to Immune Regulation May Help Transplant Patients
11. Regulation of Infertility Clinics Needed
Post Your Comments:
(Date:7/26/2008)...device giving patients freedom of movement, better...HealthDay News) -- An automated artificial kidney ...alysis patients what the insulin pump is to diabet...al kidney (AWAK) works better than conventional di...of Clinical and Experimental Nephrology . , "W...
(Date:7/25/2008)....Y., July 25 /PRNewswire-USNewswire/ -- Anthony Sh...ty Officer and Vice President,of Strategic Plannin..., a,national foundation committed to improving U.S... foundation,s Program on Health Care Quality,Impro...m.com/cgi-bin/prnh/20080725/DC28791LOGO ), Board...
(Date:7/25/2008)...ponse after antiretroviral therapy may be due to g...thDay News) -- A new study challenges the long-hel...the immune system,s ability to restore itself afte...retroviral therapy (HAART). , From 50 percent t...nfected with HCV. Intravenous drug use is the main...
(Date:7/25/2008)...ffers patients consumers tips and encourages them ...HARRISBURG, Pa., July 25 /PRNewswire-USNewswire/ -...supports "National Patient Safety Day" which,is a ...milies to,participate fully in their healthcare by... about their surgery or illness., "We understand ...
Breaking Medicine News(10 mins):Health News:IPRO Welcomes Back Anthony Shih as Chief Quality Officer, Strategic Planning Lead 2Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 2Health News:Patient Safety Authority Supports 'National Patient Safety Day' 3
...nmentally friendly, if new figures released by the...ything to go by. The growth in emissions from va...ed the reduction in carbon dioxide emissions due t...ore efficient cars, the report said. The total CO...
...g fast in Massachusetts, resulting in calls mosqui... reservations . EEE is a potentially deadly encep...es are reluctant to go in for wholesale because of...lists. Nine regional control projects in the stat...
...ards the development of a technique that could be ...ariant CJD . The technique, which has so far been...and accelerating the replication of prions - abnor...ain tissue and are thought to cause the disease. &...
Hormone Replacement Therapy Liberation at a Cost
Other Medicine News:Health News:Eastern Equine Encephalitis Spreading Its Tentacles in Massachusetts 2Health News:Eastern Equine Encephalitis Spreading Its Tentacles in Massachusetts 3Health News:Significant Advances in VCJD Prion Detection 2Health News:Hormone Replacement Therapy Liberation at a Cost 2Health News:Hormone Replacement Therapy Liberation at a Cost 3
(Date:7/24/2008)...re/ -- Headlines claiming "soy,products lower sper...ale,preliminary study that Dr. Jorge Chavarro, pu...recollected intake of soyfoods and not on,specific...ded by many,issues, thus I feel the results should...r. Tammy Hedlund, a researcher in prostate cancer,...
(Date:7/24/2008)... -- MacroChem Corporation (OTC,Bulletin Board: MAC...rial,involving 37 patients who completed a 48-week...y study of EcoNail, a topical antifungal,lacquer f...he composite,primary efficacy endpoint of the tria... (negative fungal culture and negative KOH) and cl...
(Date:7/23/2008)...y print edition of Clinical C... /- A Roche Diagnostics-sponsored,pil...pe natriuretic peptide,(NT-proBNP) confirms the po... in predicting the risk of cardiovascular adverse ...dal anti-inflammatory drugs of,the COX inhibitor c...
(Date:7/23/2008)...arma Inc., a company developing,breakthrough molec...graphy,(PET) market, announced positive Phase I re...cer for myocardial perfusion imaging. BFPET is,Flu...ete Phase I clinical,development., BFPET is a PET...in the,heart (myocardial perfusion). Myocardial pe...
Breaking Medicine Technology:Soyfoods Do Not Impact Sperm Count 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 3MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 4MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 5Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 3Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 4FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 3Rheumatoid Arthritis Treatment Guidelines Updated 22828 1Rheumatoid Arthritis Treatment Guidelines Updated 22828 2Rheumatoid Arthritis Treatment Guidelines Updated 22828 3First Nursing Facility Installation of Masimo Patient SafetyNet 28TM 29 Goes Live With Remarkable Results 22825 1First Nursing Facility Installation of Masimo Patient SafetyNet 28TM 29 Goes Live With Remarkable Results 22825 2First Nursing Facility Installation of Masimo Patient SafetyNet 28TM 29 Goes Live With Remarkable Results 22825 3First Nursing Facility Installation of Masimo Patient SafetyNet 28TM 29 Goes Live With Remarkable Results 22825 4First Nursing Facility Installation of Masimo Patient SafetyNet 28TM 29 Goes Live With Remarkable Results 22825 5American Airlines Miles for the Cure Campaign Raises More Than 24600 000 for Susan G Komen for the Cure 28R 29 22822 1American Airlines Miles for the Cure Campaign Raises More Than 24600 000 for Susan G Komen for the Cure 28R 29 22822 2American Airlines Miles for the Cure Campaign Raises More Than 24600 000 for Susan G Komen for the Cure 28R 29 22822 3First CyberKnife System to be Installed in Canada 22819 1First CyberKnife System to be Installed in Canada 22819 2First CyberKnife System to be Installed in Canada 22819 3First CyberKnife System to be Installed in Canada 22819 4
...ort Rationale for Targeting Pro-Inflammatory,Prote...e-FirstCall/ --,MedImmune, Inc. today announced th...ing a role for high mobility group box,protein-1 (...ology,of systemic autoimmune diseases such as syst...toid arthritis. Data to be,published in the May 20...
...pril 19, 2007 /PRNewswire-FirstCall/ --,VioQuest P...aceutical company focused on acquiring, developing...nounced data from its,preclinical studies of VQD- ...treatment of solid and hematologic tumors.,Pre-cli...2007,Annual Meeting of the American Association fo...
Other Medicine Technology:MedImmune Publishes New Data in Nature Immunology Demonstrating The,Role HMGB1 May Play in Systemic Autoimmune Diseases 2MedImmune Publishes New Data in Nature Immunology Demonstrating The,Role HMGB1 May Play in Systemic Autoimmune Diseases 3VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 2VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 3VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 4VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 5
...ly adjustable dispensing head, and disposable, pre...aralleled flexibility and cost-efficiency to micro... of its kind to offer fast dispensing of fluids in...lso offers the added benefit of being able to acco...
The WellPro 384 is designed for use with 384 well microplates. It utilizes a 24 channel liquid head and can perform serial dilutions in a 16 or 24 across format, and plate to plate transfers and plat
The Labcyte Echo 550 compound reformatter performs direct microplate-to-microplate transfers of droplets down to 5 nL using a new "touchless" transfer technology based on focused acoustic energy. Mon
Precise, nanoliter-volume liquid handling capability allows you to accurately dispense volumes as small as 5 nanoliters. Precision robotics and flexible software ensure accurate, repeatable X/Y motio
Medicine Products: